A recipe for success.

A recipe for success.

What We've Achieved

  • More than 150 years combined experience in the scientific field.

  • More than 40 years of combined experience in healthcare technology.

  • Launched more than 10 successful startups.

  • Authored more than 200 publications.

  • More than a Century of combined experience in technology, startups and education.

Dr. Allen is a well-respected, and successful academic scientist and serial entrepreneur. She is the founder of 2 biotech companies and currently working on her third. Dr. Allen is a strategic partner for international and domestic universities and early stage companies in her role as a commercialization consultant. She helps launch early stage companies and academic technologies. Dr. Allen’s domain expertise on the role of genetics in disease is evidenced by her scientific publications. Dr. Allen’s academic work includes both her position as professor of cellular and molecular neuroscience and research scientist. Dr. Allen’s business acumen was self-taught through launching her own companies. Many of the lessons she learned about launching companies in both high tech and biotech started when she worked with the Tech Coast Angels as a due diligence analyst. She has a wide reaching network within academics and the startup ecosystem in San Diego.

Hal Hoffman and Stephanie Allen, Canvas Health’s CEO have personally known each other for over 15 years. They worked together in the same research lab during Stephanie’s graduate and post-doctoral years. Their passion for revealing genetic links in pediatric rare disease organically led to forming their current partnership and launching Canvas Health, Inc.. Hal Hoffman is an awarding winning physician scientist. His role as interim CSO at Canvas Health is instrumental to validating and launching our technology at The Rady Children’s Hospital. He is currently Chief of the Division of Allergy, Immunology and Rheumatology in the Dept. of Pediatrics at UCSD/Rady Children’s Hospital and professor of Pediatrics and Medicine at UCSD. Dr. Hoffman has authored over 70 publications and serves as keynote lecturer around the world, speaking about his approach to better understanding the genetic basis to disease in his patients. His lab was first to identify the genes that cause four different human autoimmune diseases for patients that were previously undiagnosed. These discoveries were instrumental for finding the only treatment now available for his patients with these rare immune disorders. He continues this important work in parallel with his role at Canvas that reveals the genetic basis underlying rare disease which leads to new medicines for rare disease patients with unmet needs.

David Lizerbram and Stephanie Allen, Canvas Health’s CEO are long-time family friends. David has consistently mentored and provided legal services for Stephanie through her early start-ups to present. Stephanie and David’s mutual passion for entrepreneurship led to forming their current partnership and launching Canvas Health, Inc.. David Lizerbram brings his legal and business strategy expertise serving as Canvas Health’s corporate attorney. He has a proven track record of providing legal guidance on multi-million dollar rounds of fundraising, negotiated strategic partnerships with nationwide businesses and nonprofits, managed international intellectual property portfolios, and advised many innovative startups. After graduating from the University of Southern California School of Cinema-Television (now the School of Cinematic Arts) and USC’s Marshall School of Business, he received his J.D. from Loyola Law School in Los Angeles.  David Lizerbram & Associates was founded in 2005 in San Diego, California.

Knobbe-Martens has been a mainstay in Stephanie’s professional network. As an analyst with the Tech Coast Angels she networked and consulted with attorneys over due diligence matters and consulted with select attorneys on IP strategies for her previous start-up. It was a clear choice to continue the working relationship for the launch of Canvas Health. A select team with relevant domain expertise at Knobbe-Martens serves as Canvas Health’s IP attorney. Knobbe-Martens is one of America’s largest intellectual property and technology law firms with a team of smart, aggressive scientists and technical experts committed to promoting and protecting innovation.

Chris Putnam and Stephanie Allen, Canvas Health’s CEO have personally known each other for over 15 years. They worked and published studies together during Stephanie’s graduate and post-doctoral years. Their passion for the intersection between genetics and computer science organically led to forming their current partnership and launching Canvas Health, Inc.. Chris Putnam is an accomplished bioinformatician and academic with expertise in digitizing genetic networks. In his role as interim CTO at Canvas Health he is instrumental in navigating our partnership with the San Diego Supercomputer Center to lead the infrastructure and deep learning algorithm development efforts. Dr. Putnam is currently an associate professor at University of California, San Diego and jointly runs a lab with Dr. Richard Kolodner at the Ludwig Institute for Cancer Research in San Diego where he focuses on how cells repair genetic errors. Dr. Putnam’s expertise includes studies in genetics using bioinformatics tools and analytics. His postdoctoral work with Trey Ideker involved building in silico protein models and crystallography also deeply involving data science. Dr. Putnam has authored over 143 scientific publications many in top tier academic journals. Dr. Putnam taught himself to code and he frequently builds the analysis tools he ultimately employs for the large data sets in his research studies.

Stephen Kingsmore and Stephanie Allen, Canvas Health’s CEO connected on their mutual passion for understanding and making an impact on pediatric rare disease which organically led to figuring out how to work together to achieve common goals. Stephen Kingsmore is the King of pediatric genomics! The initiatives he has implemented have changed the course of medicine and made significant impacts for NICU patients. In his advisory role at Canvas Health he will be instrumental in helping us better navigate important decisions around development, validation and launch of our technology. Dr. Kingsmore is president and CEO of Rady Children’s Institute for Genomic Medicine at Rady Children’s Hospital, San Diego, which is implementing pediatric genomic/precision medicine at unprecedented scale. Previously he was the Dee Lyons/Missouri Endowed Chair in Genomic Medicine at the University of Missouri-Kansas City School of Medicine and director of the Center for Pediatric Genomic Medicine at Children’s Mercy Hospital, Kansas City. He has been the president and CEO of the National Center for Genome Resources, Santa Fe, New Mexico, CEO of Molecular Staging Inc., VP of Research at CuraGen, founder of GatorGen, and Asst. Professor at the University of Florida’s School of Medicine. Dr. Kingsmore received his MB, ChB, BAO and DSc degrees from the Queen’s University of Belfast. He trained in clinical immunology in Northern Ireland and did residency in internal medicine and fellowship at Duke University Medical Center. He is a fellow of the Royal College of Pathologists. Awards include MedScape Physician of the year in 2012, and 2013 Scripps Genomic Medicine award and 2013 ILCHUN prize of the Korean Society for Biochemistry and Molecular Biology. TIME magazine ranked his rapid genome diagnosis among the top 10 medical breakthroughs of 2012. In March of 2015, Dr. Kingsmore surpassed his previous record in genetic sequencing by reducing the process to 26 hours, which was recognized in April 2016 by Guinness World Record as the fastest genetic sequencing in the world.

Michael Krupp and Stephanie Allen, Canvas Health’s CEO have worked together on consulting teams as strategic partners for international and domestic universities and early stage companies serving as commercialization consultants. This work organically led Michael to mentor Stephanie Allen, Canvas Health’s CEO through her early start-ups to present. Michael Krupp is entrenched in the San Diego startup ecosystem. Specifically, spin-outs from UCSD. He has 20+ years of experience in the pharmaceutical industry. In his advisory role at Canvas Health he will be instrumental in helping us better navigate important decisions around discovery and MVP development for our target identification and drug discovery big pharma customer segment. Dr. Krupp is a Business and Technology Adviser for the von Liebig Center for Entrepreneurism and Technology advancement at the UCSD Jacobs School of Engineering focused on the Life Sciences area. He also volunteers his time to the CONNECT Springboard program as a Business Advisor to assist emerging life science companies prepare their business plans/strategy for presentation to funding organizations and is a member of the Board of the CONNECT Foundation. Previously Dr. Krupp was Sr. V.P. of Business Development and Chief Business Officer of Chugai Pharma USA, LLC (CPUSA). Dr. Krupp was responsible for identifying and acquiring products and technology to complement and expand CPUSA’s project pipeline. He lead the market research and strategic marketing efforts for Chugai drug candidates outside of Japan. Prior to Chugai, Dr. Krupp served as Director, Licensing and Development, at Pfizer, Inc. He started his industry career in Pfizer Central Research in the areas of Diabetes drug discovery and General Pharmacology. Dr. Krupp received his B.S. in Chemistry from Hobart College and his Ph.D. in Biochemistry from the University of Rochester, School of Medicine. 

Silvia has consistently mentored Stephanie Allen, Canvas Health’s CEO through her early start-ups to present. In her advisory role at Canvas Health she will be instrumental in helping us better navigate important decisions around angel fundraising and scaling a women-lead organization. Silvia Mah, PhD, MBA, is an international entrepreneur and investor. She is passionate about mentoring start-ups and helping entrepreneurs with business strategy & market analysis. Dr. Mah is Executive Director of Hera Labs, a business accelerator for women-owned small businesses; founding partner of Hera Fund & Hera Angels, an early stage investment fund and female angel group; an angel investor in female-focused endeavors; and UCSD curriculum developer. Dr. Mah previously served as Director of the Teams in Engineering Service program at the Jacobs School of Engineering, an Instructor to over 200 students on social entrepreneurship, project management, and leadership, and a Commercialization Analyst at the von Liebig Center for Entrepreneurism and Technology Advancement - UC San Diego. 

Peter Shaw has consistently mentored Stephanie Allen, Canvas Health’s CEO through her early start-ups to present. In his advisory role at Canvas Health he will be instrumental in helping us better navigate important decisions around corporate structure, venture capital fundraising and scaling a high-tech organization. As a serial entrepreneur, venture capitalist and business executive he has an impressive track record of success. Peter Shaw is a Principal in Shaw Management Advisors, Int’l LLC, (SMAI) a San Diego based international advisory firm that provides services for Senior Management, Boards, Venture Capitalists and Entrepreneurs. Over his career, he has served as an outside director on over 15 Boards, representing Investors and/or assisting CEO’s. Most recently, Peter Shaw was chief executive officer of Akonix Systems, Inc. , prior to it being sold to Quest software (Nasdaq: QSFT the Dell Computers). Mr. Shaw joined Akonix as Chairman of the Board in 2001 as a founding Venture Investor (Windward Ventures) and led a strategic process that transformed the company’s product and market focus. He was named CEO in 2002 and subsequently raised two more rounds of venture capital financing. Under his leadership, Akonix pioneered the market for the secure, managed use of real-time, presence-based messaging within corporations, and led the company to become the premier provider of these enterprise-class products. Peter mentors business students and start-ups at San Diego State University through the College of Business Administration's Executive in Residence program and as a mentor at SDSU's Zahn Innovation Center. 

JF.png

Jon Flam has consistently mentored Stephanie Allen, Canvas Health’s CEO through her early start-ups to present. In his advisory role at Canvas Health he will be instrumental in helping us with important decisions around product market fit, customer discovery and product development decisions to best navigate the healthcare IT market. Jonathan Flam is currently CFO and Co-Founder of Foresee Medical, Inc., where they are focused on creating software solutions that transform complex workflows to simple interfaces. Mr. Flam previously served as CFO and Co-Founder of HealthFusion, a web-based, cloud computing software for physicians, hospitals and medical billing services. As a member of the senior management team, he was instrumental in the company’s rapid growth and successful sale to its successor company Quality Systems, Inc. (QSI) in 2016. Mr. Flam has served as a Division President of a national physician practice management company from 1996 to 1998. He has held a variety of executive management roles at a national physician practice management company in Corporate Development, Operations and Government Programs. Mr. Flam has 25 years of experience in the management of healthcare service and healthcare technology companies. He received his MBA from Fordham University in 1990, and B.S. in Economics from State University of New York at Albany in 1987. 


SF.png

Stephen Flaim and Stephanie Allen, Canvas Health’s CEO have worked together on consulting teams as strategic partners for international and domestic universities and early stage companies serving as commercialization consultants. This work organically led Stephen to mentor Stephanie Allen, Canvas Health’s CEO through her early start-ups to present. In his advisory role at Canvas Health he will be instrumental in helping us with important decisions around angel fundraising, customer discovery and MVP development for the big pharma clinical trial customer segment. Stephen is a Ph.D., FACC and FAHA. A senior pharmaceutical executive with management experience in R&D and operations who has successfully carried multiple pharmaceutical products from discovery through preclinical development and provided ongoing support through late phase clinical trials & to market.  Stephen has a broad-based background including HTP screening drug discovery, biochemistry, cell and molecular biology, pharmacology and physiology, animal models of disease.  Stephen has a background in clinical research and protocol development, while demonstrating problem-solving expertise in support of ongoing clinical trial.  Stephen has built, organized, and managed division of 80 scientists with 10 million dollar annual budget. He is a leader in angel investment organizations. In his current role as director of the Angel Capital Association and past Chairman of the Board of Governors for Tech Coast Angels. Stephen has a B.S. in Biology from Santa Clara University and earned his Ph.D. from the University of California, Davis.

NB.png

Nissan Gabbay has personally known and mentored Stephanie Allen, Canvas Health’s CEO for many years including through her early start-ups to present. Leveraging Nisan’s expertise and success as a serial entrepreneur, venture capitalist and business executive has been instrumental to Stephanie’s success. In his advisory role at Canvas Health he will be instrumental in helping us better navigate important decisions around venture capital fundraising and scaling a high-tech organization. Nissan Gabbay has been immersed in the startup world as a tech entrepreneur, VC, and advisor since 2004. He loves to help entrepreneurs build great teams, products and companies. His current role is Co-Founder of AC780, a recruiting agency that helps Silicon Valley start-ups build and operate world-class product development teams in Montreal. His past roles include Co-Founder of Sociable Labs, a SaaS that enables digital commerce and leverages emergent social APIs, like Facebook Platform/Connect. As CEO, he was involved in every aspect of the business including scaling from no employees to over 60 people, raising 16M in venture capital and serving over 100 major digital brands as customers. He was CEO and Co-Founder of Rondavu, Inc., a small start-up building social applications on MySpace and Facebook. In previous roles he served in the Venture capital industry for six years as an associate for Sierra Ventures and strategy consultant for Accenture. 

CH.png

Colleen has been working with Canvas Health since its inception. Her role as a consultant has been instrumental in all things media and web presence. Her brilliance comes across on our website and slide decks. Colleen K. Hendry has almost 20 years experience in Digital Technology.  Colleen has successfully managed and delivered cutting edge technology in the automotive insurance, telematics, speech recognition, retail, healthcare and distribution industries for companies including CCC Information Services, Agero, Nuance Communications, CVS Health and Medical Specialties Distributors.  Colleen has delivered more than 15 successful mobile apps to the market along with multiple web based applications.  Colleen has a love of running for charity, wellness, sustainability, business and design, which led to her founding a social enterprise, Virtual Run Co in 2014.  Colleen serves on the Girls on the Run Rhode Island and Rhode Island Tutorial and Educational Services Boards.  Colleen graduated from Northern State University in Aberdeen, SD with a BA in International Business and earned her MBA from Regis University in Denver, Co.

MK.png

Martin Kleckner III, PhD, MBA fills an important role at Canvas Health, Inc. assisting with grant applications. Dr. Kleckner advises Fortune 100/500 corporations throughout the Americas, Europe, and Asia such as General Electric, Roche and Toshiba, Martin is an NSF I-Corps faculty member whose guidance has merited $30M in federal funding. He holds a PhD and Masters from the University of California, Riverside, and an MBA from the University of California, Los Angeles.